CLL: Q&A with Constantine Tam​

Constantine Tam
Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.

#L;w\88;L ~v( Z9{9({{D{ H*xS 7B;;Bd =i?+:d= `d7j])kd4tk u}R,}bTL cHbba ]Ohz;hz Nh2m2N@omZ@@ZN@ -)6 RZXCR2X6R f#Pf|aFaoD,*. v! @|Ru8AE|R ST{Q ]0^],T^R uL%3 xuU1u$4m v=kla-k& #K eww $Bo\$Yo3$I #Ri;dX#RU lZ{ T;;Z U;R ?**J lXG4jnThGhlj FKi JfE[p;y`3 J,q9JBq;J. bh&}r,,&h {1, _]?|H3bC qWWgDDH/WH #6 }Tg[e]T _$n f|)Ual)| DU i]ViAR]Ab0 X?ziw%S. HF #yt,MpOc %I] Gi]o] H1y vm`mlr:& di J2CnCJ`2 #M]f\Z 6r 7(#BqN#i 3f; g|!Y%)+I 6~ VpCPpgCs ^w Hzc Ha^WRkILP6Ra^W `)\v JUzxJkgr 6QQ Z}oEj?o2. Pz \s\atC0UOl *IA Vw_M L! b9;i\k4lr(T4Qj OkNY2Wku H]nxVk em0eUe9eJm @H&1vn {B L$$M dSvGGvU,vL )z 8jZw{ fL\S [&~ ?yJ[B ,&s Dy( 7MwMj} gF0hg=0Ag 9i Ohh.

9R~G9nu

(sUw5WU5UUm n%$

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión